Results 11 to 20 of about 1,599,346 (327)

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm [PDF]

Journal of Visualized Experiments, 2016
Transduction-transplantation is a quick and efficient way to model human hematologic malignancies in mice. This technique results in expression of the gene of interest in hematopoietic cells and can be used to study the gene's role in normal and/or malignant hematopoiesis.
Nguyen, Thanh Kim, Morse, Sarah J, Fleischman, Angela G   +2 more
openaire   +6 more sources

Prognostic Role of Cell Blood Count in Chronic Myeloid Neoplasm and Acute Myeloid Leukemia and Its Possible Implications in Hematopoietic Stem Cell Transplantation [PDF]

Diagnostics, 2022
Numerous prognostic indexes have been developed in hematological diseases based on patient characteristics and genetic or molecular assessment. However, less attention was paid to more accessible parameters, such as neutrophils, lymphocytes, monocytes ...
Olga Mulas, Brunella Mola, Clelia Madeddu, Giovanni Caocci, Antonio Macciò, Giorgio La Nasa   +5 more
doaj   +3 more sources

Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation [PDF]

Case Reports in Hematology, 2013
Therapy-related myeloid neoplasm (t-MN) is a subtype of acute myeloid leukemia with adverse cytogenetics and poor overall prognosis despite intensive induction chemotherapy and allogeneic hematopoietic cell transplantation (allo-HCT).
Richard J. Lin, Richard A. Larson, Koen van Besien, Elizabeth S. Rich   +3 more
doaj   +2 more sources

Hepatocellular carcinoma associated with progressive intrahepatic familial cholestasis type 2: a case report [PDF]

Clinical Transplantation and Research
Progressive familial intrahepatic cholestasis type 2 (PFIC2) is an autosomal recessive disorder typically presenting in infancy with cholestasis and rapidly progressing to cirrhosis.
João Miguel Pimentel, Susana Nobre, Rui Caetano Oliveira, Ricardo Martins, Maria Augusta Cipriano   +4 more
doaj   +2 more sources

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation. [PDF]

Biology of Blood and Marrow Transplantation, 2014
Transformed acute myeloid leukemia in myelofibrosis results in a median survival of less than 5 months. We identified 46 of 1048 myelofibrosis patients in the European Group for Blood and Marrow Transplantation registry who received allogeneic stem cell ...
H. Alchalby, T. Zabelina, T. Stübig, A. van Biezen, M. Bornhäuser, P. Di Bartolomeo, D. Beelen, J. Cahn, P. Dreger, William Schroyens, T. D. de Witte, E. Olavarría, N. Kröger   +12 more
semanticscholar   +2 more sources

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation [PDF]

Case Reports in Hematology, 2015
Monitoring of the JAK2 V617F allele burden in myeloproliferative neoplasms after allogeneic stem cell transplantation is useful to determine levels of residual disease and has the potential to detect early relapse and guide subsequent clinical ...
Stephen E. Langabeer, James Nolan, Karl Haslam, Lindsey Clarke, Richard Flavin, Eibhlin Conneally   +5 more
doaj   +2 more sources

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually [PDF]

Bone Marrow Transplantation, 2016
A record number of 40 829 hematopoietic stem cell transplantation (HSCT) in 36 469 patients (15 765 allogeneic (43%), 20 704 autologous (57%)) were reported by 656 centers in 47 countries to the 2014 survey. Trends include: continued growth in transplant
Jakob R. Passweg, H. Baldomero, P. Bader, C. Bonini, S. Cesaro, P. Dreger, R. Duarte, C. Dufour, J. Kuball, D. Farge-Bancel, A. Gennery, N. Kröger, F. Lanza, A. Nagler, A. Sureda, M. Mohty   +15 more
semanticscholar   +2 more sources

Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation. [PDF]

Biology of Blood and Marrow Transplantation, 2019
We report the outcomes of 51 patients who underwent unmanipulated haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplantation cyclophosphamide (PT-Cy) and antithymocyte globulin (ATG), from peripheral blood stem cells ...
R. Duléry, J. Bastos, A. Paviglianiti, F. Malard, E. Brissot, G. Battipaglia, C. Médiavilla, F. Giannotti, A. Banet, Zoé Van de Wyngaert, T. Ledraa, R. Belhocine, S. Sestili, Rosa Adaeva, S. Lapusan, F. Isnard, O. Legrand, A. Vekhoff, M. Rubio, A. Ruggeri, M. Mohty   +20 more
semanticscholar   +2 more sources

Myeloproliferative neoplasm harboring both monosomy 7 and an ALK/ROS1 fusion gene: Proposal for a new disease entity [PDF]

eJHaem
Introduction We present a case of a 9‐year‐old girl diagnosed with a myeloproliferative neoplasm (MPN) harboring both monosomy 7 and an ALK/ROS1 fusion gene.
Hideki Yoshida, Shinya Osone, Madoka Konishi, Seiji Tanaka, Tohru Inaba, Toshihiko Imamura, Tomoko Iehara   +6 more
doaj   +2 more sources

Renal Transplantation with Kidneys Affected by Tumours [PDF]

International Journal of Nephrology, 2010
Renal transplantation confers improvement in quality of life and survival when compared to patients on dialysis. There is a universal shortage of organs, and efforts have been made to overcome this shortage by exploring new sources.
Muhammad Arslan Khurram, Aliu Oladipupo Sanni, David Rix, David Talbot   +3 more
doaj   +2 more sources